Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japan's MHLW Sets Size Requirements For Transdermal Patch Drug Listing

This article was originally published in PharmAsia News

Executive Summary

Regarding price listing for non-steroid anti-inflammation transdermal patches, Japan's Ministry of Health, Labor and Welfare ruled that unless there is a medical need requiring a special size, no new products beyond the current three patch sizes and two tape sizes will be listed. The sizes for patches are 7cm×10cm, 10cm×12cm, 14cm×20cm, the sizes for tapes are 7cm×10cm and 10cm ×14cm. MHLW hopes to reduce inventory burdens and clarify the specifications and requirements for drug approval and price listing. (Click here for more - Japanese language
UsernamePublicRestriction

Register

SC072679

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel